Cardiac sarcoidosis: Electrophysiological outcomes on long-term follow-up and the role of the implantable cardioverter-defibrillator

Journal of Cardiovascular Electrophysiology

Volumn 25, Issue 2, 2014, Pages 171-176

  Mohsen, Amr ^a   Jimenez, Alejandro ^c   Hood, Robert E ^b   Dickfeld, Timm ^b   Saliaris, Anastasios ^b   Shorofsky, Stephen ^b   Saba, Magdi M ^d  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c WELLINGTON HOSPITAL   (New Zealand)

^d ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

cardiac sarcoid; implantable cardioverter defibrillator; sarcoidosis; sudden cardiac death; ventricular tachycardia

Indexed keywords

CARDIOMYOPATHIES; CLINICAL TRIAL; COMPLICATION; FEMALE; FOLLOW UP; HEART FUNCTION TEST; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LONGITUDINAL STUDY; MALE; MIDDLE AGED; PROCEDURES; PROGNOSIS; REPRODUCIBILITY; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

CARDIOMYOPATHIES; DEFIBRILLATORS, IMPLANTABLE; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 84894053983     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.12302     Document Type: Article

References (26)

1. Hillerdal G, Nöu E, Osterman K, Schmekel B,: Sarcoidosis: Epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis 1984; 130: 29-32.
2. Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, Iannuzzi MC,: Racial differences in sarcoidosis incidence: A 5-year study in a health maintenance organization. Am J Epidemiol 1997; 145: 234-241.
3. Silverman KJ, Hutchins GM, Bulkley BH,: Cardiac sarcoid: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978; 58: 1204-1211.
4. Roberts WC, McAllister HA Jr, Ferrans VJ,: Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group I) and review of 78 previously described necropsy patients (group II). Am J Med 1977; 63: 86-108.
5. Mehta D, Lubitz SA, Frankel Z, Wisnivesky JP, Einstein AJ, Goldman M, Machac J, Teirstein A,: Cardiac involvement in patients with sarcoidosis: Diagnostic and prognostic value of outpatient testing. Chest 2008; 133: 1426-1435.
6. Matsui Y, Iwai K, Tachibana T, Fruie T, Shigematsu N, Izumi T, Homma AH, Mikami R, Hongo O, Hiraga Y, Yamamoto M,: Clinicopathological study on fatal myocardial sarcoidosis. Ann N Y Acad Sci. 1976; 278: 455-469.
7. Tachibana T, Iwai K, Takemura T,: Study on the cause of death in patients with sarcoidosis in Japan (abstract). Presented at XII World Congress on Sarcoidosis; 1991, September 8-13; Kyoto, Japan.
8. Judson MA, Baughman RP, Teirstein AS, Terrin ML, Yeager H Jr,: Defining organ involvement in sarcoidosis: The ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 75-86.
9. Smedema JP, Snoep G, van Kroonenburgh MP, van Geuns RJ, Dassen WR, Gorgels AP, Crijns HJ,: Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands. Chest 2005; 128: 30-35.
10. Suzuki T, Kanda T, Kubota S, Imai S, Murata K,: Holter monitoring as a non-invasive indicator of cardiac involvement in sarcoidosis. Chest 1994; 106: 1021-24.
11. Patel MR, Cawley PJ, Heitner JF, Klem I, Parker MA, Jaroudi WA, Meine TJ, White JB, Elliott MD, Kim HW, Judd RM, Kim RJ,: Detection of myocardial damage in patients with sarcoidosis. Circulation 2009; 120: 1969-1977.
12. Manins V, Habersberger J, Pfluger H, Taylor AJ,: Cardiac magnetic resonance imaging in the evaluation of cardiac sarcoidosis: An Australian single-centre experience. Intern Med J 2009; 2: 77-82.
13. Yazaki Y, Isobe M, Hiroe M, Morimoto S, Hiramitsu S, Nakano T, Izumi T, Sekiguchi M,: Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 2001; 88: 1006-1010.
14. Hiraga H, Yuwai K, Hiroe M, et al. Guideline for the diagnosis of cardiac sarcoidosis: study report on diffuse pulmonary diseases [in Japanese ]. Tokyo, Japan: Ministry of Health and Welfare, 1993; 23-24.
15. Reuhl J, Schneider M, Sievert H, Lutz FU, Zieger G,: Myocardial sarcoidosis as a rare cause of sudden cardiac death. Forensic Sci Int 1997; 89: 145-53.
16. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008; 51: e1-62.
17. Schuller JL, Olson MD, Zipse MM, Schneider PM, Aleong RG, Wienberger HD, Varosy PD, Sauer WH,: Electrocardiographic characteristics in patients with pulmonary sarcoidosis indicating cardiac involvement. J Cardiovasc Electrophysiol 2011; 22: 1243-1248.
18. Kron J, Sauer W, Schuller J, Bogun F, Crawford T, Sarsam S, Rosenfeld L, Mitiku TY, Cooper JM, Mehta D, Greenspon AJ, Ortman M, Delurgio DB, Valadri R, Narasimhan C, Swapna N, Singh JP, Danik S, Markowitz SM, Almquist AK, Krahn AD, Wolfe LG, Feinstein S, Ellenbogen KA,: Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis. Europace. 2013; 15: 347-354.
19. Betensky BP, Tschabrunn CM, Zado ES, Goldberg LR, Marchlinski FE, Garcia FC, Cooper JM,: Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators. Heart Rhythm 2012; 9: 884-891.
20. Schuller JL, Zipse M, Crawford T, Bogun F, Beshai J, Patel AR, Sweiss NJ, Nguyen DT, Aleong RG, Varosy PD, Weinberger HD, Sauer WH,: Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis. J Cardiovasc Electrophysiol 2012; 23: 925-929.
21. Banba K, Kusano KF, Nakamura K, Morita H, Ogawa A, Ohtsuka F, Ogo KO, Nishii N, Watanabe A, Nagase S, Sakuragi S, Ohe T,: Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis. Heart Rhythm 2007; 4: 1292-1299.
22. Flemming H, Bailey S,: Cardiac sarcoidosis. In: James DG, ed. Sarcoidosis and Other Granulomatous Disorders (vol 73). New York, NY: Marcel Dekker, 1994; 323-334.
23. Chapelon-Abric C, de Zuttere D, Duhaut P, Veyssier P, Wechsler B, Huong DL, de Gennes C, Papo T, Blétry O, Godeau P, Piette JC,: Cardiac sarcoidosis: A retrospective study of 41 cases. Medicine (Baltimore) 2004; 83: 315-34.
24. Fleming HA, Bailey SM,. Sarcoid heart disease. J R Coll Physicians Lond 1981; 15: 245-6, 249-53.
25. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH,: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-37.
26. Takada K, Ina Y, Yamamoto M, Satoh T, Morishita M,: Prognosis after pacemaker implantation in cardiac sarcoidosis in Japan. Clinical evaluation of corticosteroid therapy. Sarcoidosis 1994; 11: 113-7.